ArticleClinical drug investigation2024

Health and Economic Outcomes of Pembrolizumab in the Treatment of Metastatic Non-small Cell Lung Cancer (mNSCLC) and Melanoma in Italy.

Martina Paoletti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.